Monitoring Crimean-Congo haemorrhagic fever virus RNA shedding in body secretions and serological status in hospitalised patients, Turkey, 2015
- PMID: 32183931
- PMCID: PMC7078823
- DOI: 10.2807/1560-7917.ES.2020.25.10.1900284
Monitoring Crimean-Congo haemorrhagic fever virus RNA shedding in body secretions and serological status in hospitalised patients, Turkey, 2015
Abstract
IntroductionCrimean-Congo haemorrhagic fever (CCHF) is a tick-borne disease in Africa, Asia, the Balkan peninsula, the south-east of Europe and the Middle East, with mortality rates of 3-30%. Transmission can also occur through contact with infected animals or humans.AimThis observational, prospective case series aimed to investigate detectable viral genomic RNA in whole-body fluids and antibody dynamics in consecutive daily samples of patients diagnosed with CCHF until discharge from hospital.MethodsWe tested 18 patients and 824 swabs and sera with RT-PCR and 125 serum samples serologically.ResultsThe longest duration until clearance of viral RNA was 18 days from serum collection and 18, 15, 13, 19 and 17 days, respectively, from nasal, oral, genital (urethral or vaginal) and faecal swab, and urine. In seven patients, viral load decreased in serum at the same time as it increased in urine or persisted at the same logarithmic values. Despite clearance in serum, viral RNA was detected in faeces and genital swabs in two and three patients, respectively. Viral clearance from body fluids occurred earlier than from serum in eight patients on ribavirin treatment. The shortest seroconversion time was 3 days after symptom onset for IgM and IgG. Seroconversion of IgG occurred until Day 14 of symptoms.ConclusionWe report persistence of viral RNA in urine, faeces and genital swabs despite serum clearance. This may indicate a need for extending isolation precautions, re-evaluating discharge criteria and transmission risk after discharge, and considering oral swabs as a less invasive diagnostic alternative.
Keywords: CCHF; Crimean–Congo haemorrhagic fever virus; RT-PCR; antibody response; faeces; genital swab; serum; urine; viral shedding.
Conflict of interest statement
Figures
Similar articles
-
[Evaluation of PCR and ELISA-IgM results in the laboratory diagnosis of Crimean-Congo haemorrhagic fever cases in 2008 in Turkey].Mikrobiyol Bul. 2010 Jan;44(1):57-64. Mikrobiyol Bul. 2010. PMID: 20455399 Turkish.
-
A patient with Crimean-Congo hemorrhagic fever serologically diagnosed by recombinant nucleoprotein-based antibody detection systems.Clin Diagn Lab Immunol. 2003 May;10(3):489-91. doi: 10.1128/cdli.10.3.489-491.2003. Clin Diagn Lab Immunol. 2003. PMID: 12738657 Free PMC article.
-
Sensitive and specific detection of Crimean-Congo Hemorrhagic Fever Virus (CCHFV)-Specific IgM and IgG antibodies in human sera using recombinant CCHFV nucleoprotein as antigen in μ-capture and IgG immune complex (IC) ELISA tests.PLoS Negl Trop Dis. 2018 Mar 26;12(3):e0006366. doi: 10.1371/journal.pntd.0006366. eCollection 2018 Mar. PLoS Negl Trop Dis. 2018. PMID: 29579040 Free PMC article.
-
[Crimean-Congo hemorrhagic fever: basics for general practitioners].Med Trop (Mars). 2010 Dec;70(5-6):429-38. Med Trop (Mars). 2010. PMID: 21520641 Review. French.
-
Crimean-Congo hemorrhagic fever in Turkey: Current status and future challenges.Antiviral Res. 2016 Feb;126:21-34. doi: 10.1016/j.antiviral.2015.12.003. Epub 2015 Dec 13. Antiviral Res. 2016. PMID: 26695860 Review.
Cited by
-
Sexual Transmission of Arboviruses: A Systematic Review.Viruses. 2020 Aug 25;12(9):933. doi: 10.3390/v12090933. Viruses. 2020. PMID: 32854298 Free PMC article.
-
Immune responses in multiple hosts to Nucleocapsid Protein (NP) of Crimean-Congo Hemorrhagic Fever Virus (CCHFV).PLoS Negl Trop Dis. 2021 Dec 1;15(12):e0009973. doi: 10.1371/journal.pntd.0009973. eCollection 2021 Dec. PLoS Negl Trop Dis. 2021. PMID: 34851958 Free PMC article.
-
Sequential determination of viral load, humoral responses and phylogenetic analysis in fatal and non-fatal cases of Crimean-Congo hemorrhagic fever patients from Gujarat, India, 2019.PLoS Negl Trop Dis. 2021 Aug 30;15(8):e0009718. doi: 10.1371/journal.pntd.0009718. eCollection 2021 Aug. PLoS Negl Trop Dis. 2021. PMID: 34460819 Free PMC article.
-
A Novel RT-LAMP for the Detection of Different Genotypes of Crimean-Congo Haemorrhagic Fever Virus in Patients from Spain.Int J Mol Sci. 2023 Mar 29;24(7):6411. doi: 10.3390/ijms24076411. Int J Mol Sci. 2023. PMID: 37047384 Free PMC article.
-
Replicon particle vaccination induces non-neutralizing anti-nucleoprotein antibody-mediated control of Crimean-Congo hemorrhagic fever virus.NPJ Vaccines. 2024 May 23;9(1):88. doi: 10.1038/s41541-024-00877-1. NPJ Vaccines. 2024. PMID: 38782933 Free PMC article.
References
-
- Gargili A, Estrada-Peña A, Spengler JR, Lukashev A, Nuttall PA, Bente DA. The role of ticks in the maintenance and transmission of Crimean-Congo hemorrhagic fever virus: A review of published field and laboratory studies. Antiviral Res. 2017;144:93-119. 10.1016/j.antiviral.2017.05.010 - DOI - PMC - PubMed
-
- European Centre for Disease Prevention and Control (ECDC). Rapid risk assessment: Crimean–Congo haemorrhagic fever in Spain – 9 September 2016. Stockholm: ECDC; 2016. Available from: https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-cr...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources